Fitzpatrick Alexander A 4
4 · ARS Pharmaceuticals, Inc. · Filed Jan 3, 2025
Insider Transaction Report
Form 4
Fitzpatrick Alexander A
Chief Legal Officer
Transactions
- Award
Stock option (right to buy)
2025-01-02+152,300→ 152,300 totalExercise: $10.71Exp: 2035-01-01→ Common Stock (152,300 underlying)
Footnotes (1)
- [F1]The shares subject to the option shall vest in a series of 48 equal monthly installments measured from January 1, 2025.